Postoperative adjuvant gemcitabine and concurrent radiation after curative resection of pancreatic head carcinoma: a phase II study
- 1 July 2003
- journal article
- clinical trial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 56 (4) , 974-980
- https://doi.org/10.1016/s0360-3016(03)00164-0
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trialThe Lancet, 2001
- Continuing controversy over adjuvant therapy of pancreatic cancerThe Lancet, 2001
- Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicatorsJournal of Gastrointestinal Surgery, 2000
- Adjuvant Radiotherapy and 5-Fluorouracil After Curative Resection of Cancer of the Pancreas and Periampullary RegionAnnals of Surgery, 1999
- AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinomaGastroenterology, 1999
- Efficacy of 5FU + cisplatin (FUP) compared to bolus 5FU (FU) in advanced pancreatic carcinoma (APC)European Journal Of Cancer, 1999
- Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: Postoperative Adjuvant Chemoradiation Improves SurvivalAnnals of Surgery, 1997
- Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head regionCancer, 1995
- Long-Term Survival After Resection for Ductal Adenocarcinoma of the Pancreas Is It Really Improving?Annals of Surgery, 1995
- Pancreatic CancerArchives of Surgery, 1985